SK

Sunil Kumar Pankaj

Active Director Designated Partner DIN 08376427
DIN 08376427 First appointment Feb 2019 Primary industry Electrnoics
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Feb 2019
Shareholding value β€’β€’β€’β€’ Premium profile

About Sunil Kumar Pankaj

Data last updated:

Sunil Kumar Pankaj is a Designated Partner at Theomed Pharmaceuticals Llp (since 2019) and Director at Thiomeda Pharmaceuticals Private Limited (since 2019). The companies operate in Electrnoics and Trading.

DIN 08376427
Primary Designation Designated Partner
Industry Electrnoics
First Appointment 27 Feb 2019
Oldest Company Age 7 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner04 Sep 20192019Active
Director27 Feb 20192019Active

Board colleagues of Sunil Kumar Pankaj

Directorship timeline

Open interactive timeline →
Thiomeda Pharmaceuticals Private Limited
Theomed Pharmaceuticals Llp
Premium access

Shareholding and investment profile for Sunil Kumar Pankaj

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sunil Kumar Pankaj

Sunil Kumar Pankaj currently holds 2 directorships: Theomed Pharmaceuticals Llp (Designated Partner, since 04 Sep 2019); Thiomeda Pharmaceuticals Private Limited (Director, since 27 Feb 2019).

Sunil Kumar Pankaj was first appointed on 27 Feb 2019 as Director at Thiomeda Pharmaceuticals Private Limited.

The current boards of Sunil Kumar Pankaj's companies include Anil Kumar Ranjan (Theomed Pharmaceuticals Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available